Statistics for Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels
Total visits
| views | |
|---|---|
| Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels | 61 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| 12917_2016_Article_775.pdf | 36 |
| 12917_2016_Article_775.pdf(legacy) | 27 |
Top country views
| views | |
|---|---|
| United States | 32 |
| Germany | 18 |
| France | 11 |
| United Kingdom | 10 |
| Malaysia | 9 |
| Jamaica | 6 |
| China | 5 |
| Canada | 4 |
| Russia | 2 |
| Côte d’Ivoire | 1 |
| Egypt | 1 |
| Italy | 1 |
| South Korea | 1 |
| Sweden | 1 |
| Tunisia | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Southend | 10 |
| Kuala Lumpur | 8 |
| Kingston | 6 |
| Mountain View | 3 |
| Beijing | 2 |
| Montréal | 2 |
| Moscow | 2 |
| Abidjan | 1 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Des Moines | 1 |
| Hanoi | 1 |
| Heidelberg | 1 |
| Ottawa | 1 |
| Santa Rosa | 1 |
| Schwann | 1 |